{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:39:51Z","timestamp":1769168391117,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.rmed.2016.09.008","type":"journal-article","created":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T20:41:20Z","timestamp":1473367280000},"page":"135-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?"],"prefix":"10.1016","volume":"119","author":[{"given":"Amy","family":"Richardson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Tolley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6808-1896","authenticated-orcid":false,"given":"Jasmine","family":"Reedus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandi","family":"Bowlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Finch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher W.","family":"Sands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Self","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2016.09.008_bib1","unstructured":"COPD statistics across America. COPD Foundation website. Available at http:\/\/www.copdfoundation.org\/What-is-COPD\/COPD-Facts\/Statistics.aspx. Accessed September 8, 2014."},{"key":"10.1016\/j.rmed.2016.09.008_bib2","unstructured":"Leading Causes of Death. Available at http:\/\/www.cdc.gov\/nchs\/fastats\/leading-causes-of-death.htm. Accessed February 18, 2016."},{"key":"10.1016\/j.rmed.2016.09.008_bib3","first-page":"105","article-title":"Posthospital follow-up visits and 30-day readmission rates in chronic obstructive pulmonary disease","volume":"7","author":"Fidahussein","year":"2014","journal-title":"Risk Manag. Healthc. Policy"},{"key":"10.1016\/j.rmed.2016.09.008_bib4","unstructured":"Centers for Medicare and Medicaid Services. Readmission Reduction Program. Available from: http:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/AcuteInpatientPPS\/Readmissions-Reduction-Program.html. Accessed September 8, 2014."},{"issue":"3","key":"10.1016\/j.rmed.2016.09.008_bib5","first-page":"310","article-title":"Update in diagnosis and therapy of coexistent chronic obstructive pulmonary disease and chronic heart failure","volume":"4","author":"Zeng","year":"2012","journal-title":"J.\u00a0Thorac. Dis."},{"key":"10.1016\/j.rmed.2016.09.008_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/COPD.S31236","article-title":"The association between COPD and heart failure risk: a review","volume":"8","author":"Diez","year":"2013","journal-title":"Int. J. COPD"},{"key":"10.1016\/j.rmed.2016.09.008_bib7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1513\/AnnalsATS.201310-358OC","article-title":"Predictors of early readmission among patients aged 40 to 64 years hospitalized for COPD","volume":"11","author":"Sharif","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.rmed.2016.09.008_bib8","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1378\/chest.11-2413","article-title":"Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD","volume":"142","author":"Almagro","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2016.09.008_bib9","first-page":"551","article-title":"Risk assessment of readmissions following an initial COPD-related hospitalization","volume":"8","author":"Baker","year":"2013","journal-title":"Int. J. COPD"},{"key":"10.1016\/j.rmed.2016.09.008_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/CEOR.S74181","article-title":"Assessing the importance of predictors in unplanned hospital readmissions for chronic pulmonary disease","volume":"7","author":"Yu","year":"2015","journal-title":"Clin. Outcomes Res."},{"key":"10.1016\/j.rmed.2016.09.008_bib11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.rmed.2014.02.009","article-title":"Multicentric study on the beta-blocker use and relation with exacerbations of COPD","volume":"108","author":"Puente-Maestu","year":"2014","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2016.09.008_bib12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/thoraxjnl-2012-201945","article-title":"Association between \u03b2- blocker therapy and outcomes in patients hospitalized with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure, or hypertension","volume":"67","author":"Stefan","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2016.09.008_bib13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0954-6111(03)00168-9","article-title":"Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis","volume":"97","author":"Salpeter","year":"2003","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2016.09.008_bib14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.amjcard.2012.10.041","article-title":"Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF)","volume":"111","author":"Mentz","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.rmed.2016.09.008_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1378\/chest.14-0607","article-title":"Impact of COPD on the mortality and treatment of patients hospitalized with acute decompensated heart failure","volume":"147","author":"Fisher","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2016.09.008_bib16","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1093\/eurheartj\/eht192","article-title":"Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services","volume":"34","author":"Hawkins","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.rmed.2016.09.008_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/thoraxjnl-2015-207251","article-title":"Beta-blockers are associated with a reduction in COPD exacerbations","volume":"71","author":"Bhatt","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2016.09.008_bib18","series-title":"Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis","year":"1964"},{"key":"10.1016\/j.rmed.2016.09.008_bib19","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure","volume":"128","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2016.09.008_bib20","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD. Available from: http:\/\/www.goldcopd.org\/guidleines\/guidelines-resources.html. Accessed September 8, 2014."},{"key":"10.1016\/j.rmed.2016.09.008_bib21","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N.\u00a0Eng. J. Med."},{"key":"10.1016\/j.rmed.2016.09.008_bib22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1440-1843.2010.01781.x","article-title":"Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD","volume":"15","author":"Parappril","year":"2010","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2016.09.008_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/thx.2005.051029","article-title":"Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease","volume":"61","author":"Baker","year":"2006","journal-title":"Thorax"}],"updated-by":[{"DOI":"10.1016\/j.rmed.2016.11.013","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000}}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116302311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116302311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:35:51Z","timestamp":1760614551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611116302311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":23,"alternative-id":["S0954611116302311"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2016.09.008","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.rmed.2016.11.013","asserted-by":"object"}]},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2016.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}